ArticleIEEE intelligent systems2022
AI in Combating the COVID-19 Pandemic.
Article in IEEE intelligent systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Bridging data and theory: hybrid modelling for pharmaceutical crystallisation process development.Digital discovery · 2026Review
- Solving the Richards infiltration equation by coupling physics-informed neural networks with Hydrus-1D.Scientific reports · 2025Article
- Technological trends in epidemic intelligence for infectious disease surveillance: a systematic literature review.PeerJ. Computer science · 2025Article
- The Role of AI in Hospitals and Clinics: Transforming Healthcare in the 21st Century.Bioengineering (Basel, Switzerland) · 2024Review
- AI and data science for smart emergency, crisis and disaster resilience.International journal of data science and analytics · 2023Article
- Modeling time evolving COVID-19 uncertainties with density dependent asymptomatic infections and social reinforcement.Scientific reports · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The SARS-CoV-2 virus, the COVID-19 disease, and the resulting pandemic have reshaped the entire world in an unprecedented manner. Massive efforts have been made by AI communities to combat the pandemic. What roles has AI played in tackling COVID-19? How has AI performed in the battle against COVID-19? Where are the gaps and opportunities? What lessons can we learn to enhance the ability of AI to battle future pandemics? These questions, despite being fundamental, are yet to be answered in full or systematically. They need to be addressed by AI communities as a priority despite the easing of the omicron infectiousness and threat. This article reviews these issues with reflections on global AI research and the literature on tackling COVID-19. It is envisaged that the demand and priority of developing "pandemic AI" will increase over time, with smart global epidemic early warning systems to be developed by a global collaborative AI effort.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.